As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...